Skip to main content
Veterinary Medicines

Vimectanin DUO 50 mg/ml + 1 mg/ml oral suspension for sheep

Authorised
  • Triclabendazole
  • Ivermectin

Product identification

Medicine name:
Vimectanin DUO 50 mg/ml + 1 mg/ml oral suspension for sheep
VIMECTANIN DUO 50 mg/ml + 1 mg/ml SUSPENSION ORAL PARA OVINO
Active substance:
  • Triclabendazole
  • Ivermectin
Target species:
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ivermectin
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep (lamb)
      • Meat and offal
        27
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA51
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • 1 litre PE bottle
  • 5 litre PE bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pharma VIM Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vim Spectrum S.R.L.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4368 ESP
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0151/001
Concerned member states:
  • France
  • Greece
  • Ireland
  • Italy
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 25/06/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 6/08/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 25/06/2025